AU1463992A - Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus - Google Patents

Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus

Info

Publication number
AU1463992A
AU1463992A AU14639/92A AU1463992A AU1463992A AU 1463992 A AU1463992 A AU 1463992A AU 14639/92 A AU14639/92 A AU 14639/92A AU 1463992 A AU1463992 A AU 1463992A AU 1463992 A AU1463992 A AU 1463992A
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical compositions
immunodeficiency virus
human immunodeficiency
inhibiting protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14639/92A
Other languages
English (en)
Inventor
Anders R Karlstrom
Rodney L Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Government filed Critical US Government
Publication of AU1463992A publication Critical patent/AU1463992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU14639/92A 1991-02-28 1992-02-28 Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus Abandoned AU1463992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66202291A 1991-02-28 1991-02-28
US662022 1991-02-28

Publications (1)

Publication Number Publication Date
AU1463992A true AU1463992A (en) 1992-10-06

Family

ID=24656063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14639/92A Abandoned AU1463992A (en) 1991-02-28 1992-02-28 Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus

Country Status (2)

Country Link
AU (1) AU1463992A (fr)
WO (1) WO1992015329A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3604093A (en) * 1992-02-07 1993-09-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of HIV protease
WO1994018230A1 (fr) * 1993-02-02 1994-08-18 Procyte Corporation Inhibition de la replication du vih a l'aide de complexes peptide-cuivre
BR9406850A (pt) 1993-06-15 1997-05-27 Celltrace Communications Ltd Sistema de telecomunicaçoes
DE4431175A1 (de) * 1994-09-01 1996-04-11 Medico Pharma Vertriebs Gmbh Neue, Chelatbildner enthaltende Arzneimittel
US6989263B1 (en) * 1994-09-23 2006-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
AU6274896A (en) * 1995-06-06 1996-12-24 Procyte Corporation Stable copper(i) complexes as active therapeutic substances
AU9683998A (en) * 1998-10-13 2000-05-01 World Health Research Institute Treating hiv with edta
NL1012825C2 (nl) * 1999-08-13 2001-02-23 Faculteit Geneeskunde Universi Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV).
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US20140271919A1 (en) * 2013-03-15 2014-09-18 Chun Lim Abbott Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Genital-Rectal Areas of the Body
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62252777A (ja) * 1986-04-24 1987-11-04 Taiho Yakuhin Kogyo Kk ５−トリフルオロメチルウラシルの製造法
US5124351A (en) * 1989-02-27 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pharmaceutical compositions for the treatment of cancers susceptible to treatment with the copper complex of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof

Also Published As

Publication number Publication date
WO1992015329A1 (fr) 1992-09-17

Similar Documents

Publication Publication Date Title
AU2157192A (en) 4-aminoquinolines and pharmaceutical compositions thereof
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
GB9410987D0 (en) High dosage pharmaceutical compositions
ZA938825B (en) Pharmaceutical compositions
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
GB9308014D0 (en) Pharmaceutical compositions
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
AU3716193A (en) Pharmaceutical compositions
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
IL107653A0 (en) N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them
AU4436393A (en) Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
SG81198A1 (en) Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU6962894A (en) Compositions and methods for inhibiting replication of human immunodeficiency virus-1
GB9209874D0 (en) Pharmaceutical compositions
IL108031A0 (en) Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
AU2537992A (en) Pharmaceutical compositions
AU4504893A (en) Novel 10-diacetyl baccatine iii derivatives, preparation thereof and pharmaceutical compositions containing them
NZ245239A (en) Hemoregulatory peptides and pharmaceutical compositions
GB2275269B (en) Purified form of streptogramins,its preparation and pharmaceutical compositions containing it
GB9226377D0 (en) Pharmaceutical compositions
AP9400660A0 (en) Purified form of streptogramins, its preparation and pharmaceutical compositions containing it